Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001203450 | SCV001374616 | uncertain significance | Nemaline myopathy 9 | 2022-08-23 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 934954). This variant has not been reported in the literature in individuals affected with KLHL41-related conditions. This variant is present in population databases (rs762482219, gnomAD 0.01%). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 586 of the KLHL41 protein (p.Arg586His). |
Ambry Genetics | RCV004986937 | SCV005607328 | uncertain significance | Inborn genetic diseases | 2024-09-04 | criteria provided, single submitter | clinical testing | The c.1757G>A (p.R586H) alteration is located in exon 6 (coding exon 6) of the KLHL41 gene. This alteration results from a G to A substitution at nucleotide position 1757, causing the arginine (R) at amino acid position 586 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |